The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(Trifluoromethyl)phenylamino)-N-(2-(4-ethylphenylamino)benzo[d]oxazol-5-yl)benzamide ID: ALA4066240
Chembl Id: CHEMBL4066240
PubChem CID: 54765797
Max Phase: Preclinical
Molecular Formula: C29H23F3N4O2
Molecular Weight: 516.52
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: CCc1ccc(Nc2nc3cc(NC(=O)c4ccccc4Nc4cccc(C(F)(F)F)c4)ccc3o2)cc1
Standard InChI: InChI=1S/C29H23F3N4O2/c1-2-18-10-12-20(13-11-18)35-28-36-25-17-22(14-15-26(25)38-28)34-27(37)23-8-3-4-9-24(23)33-21-7-5-6-19(16-21)29(30,31)32/h3-17,33H,2H2,1H3,(H,34,37)(H,35,36)
Standard InChI Key: JMNLCXNDFBKGRR-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 516.52Molecular Weight (Monoisotopic): 516.1773AlogP: 8.15#Rotatable Bonds: 7Polar Surface Area: 79.19Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.30CX Basic pKa: CX LogP: 9.11CX LogD: 9.11Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.20Np Likeness Score: -1.63
References 1. Kim D, Won HY, Hwang ES, Kim YK, Choo HP.. (2017) Synthesis of benzoxazole derivatives as interleukin-6 antagonists., 25 (12): [PMID:28442260 ] [10.1016/j.bmc.2017.03.072 ]